[Pharm-policy] Fluconazole patent challenge in US

[James Love]

http://www.sec.gov/Archives/edgar/data/78003/0000930413-00-000548.txt

FLUCONAZOLE PATENT

     On February 1, 2000 the Company received notice of the filing of an
ANDA by Novopharm Limited for 50 mg, 100 mg, 150 mg and 200 mg tablets
of fluconazole alleged to be bioequivalent to DIFLUCAN. Novopharm has
certified to the FDA its position that the Company's U.S. Patent
4,404,216, which covers fluconazole, is invalid. This patent expires in
January 2004. On March 10, 2000, the Company filed a patent infringement
action under the '216 patent against Novopharm in the United States
District Court for the Northern District of Illinois.


=======================================================
James Love, Director           | http://www.cptech.org
Consumer Project on Technology | mailto:love@cptech.org 
P.O. Box 19367                 | voice: 1.202.387.8030
Washington, DC 20036           | fax:   1.202.234.5176
=======================================================